Physician profile
Jennifer D Collier
NPI 1497208425
$624.59
in general payments reported to CMS, 2019-2025
13 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $77.61 · 2023: $70.83 · 2024: $195 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.03 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $156.05 | 2021-2025 | Veozah |
| Aspira Women'S Health INC | $101.63 | 2023-2025 | Ova1 |
| Hologic Sales and Service, LLC | $92.19 | 2022-2024 | Acessa Provu System, Omni Hysteroscope, Aptima |
| Abbvie INC. | $77.77 | 2021-2025 | |
| Pfizer INC. | $66.76 | 2021-2023 | |
| Biogen, INC. | $20.35 | 2025 | Zurzuvae |
| Alexion Pharmaceuticals, INC. | $18.32 | 2021 | |
| Sage Therapeutics, LLC | $17.28 | 2022 | |
| Convatec INC. | $16.96 | 2021 | |
| Horizon Therapeutics Plc | $15.49 | 2021 | |
| Daiichi Sankyo INC. | $14.46 | 2022 | |
| Exeltis, USA INC. | $14.16 | 2021 | |
| Coopersurgical, INC. | $13.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.